Filter Results:
(974)
Show Results For
- All HBS Web
(1,927)
- People (5)
- News (486)
- Research (974)
- Events (10)
- Multimedia (13)
- Faculty Publications (509)
Show Results For
- All HBS Web
(1,927)
- People (5)
- News (486)
- Research (974)
- Events (10)
- Multimedia (13)
- Faculty Publications (509)
Sort by
- 08 Sep 2009
- Research & Ideas
The Height Tax, and Other New Ways to Think about Taxation
fair strategies in public finance? A: Tax economists generally point to a few things about current taxes that seem unwise. Probably foremost among them is the taxation of capital income, such as dividends and capital gains. There is a... View Details
Keywords: by Martha Lagace
- 28 Nov 2016
- Research & Ideas
Challenging the Belief that Liability Laws Kill Medical Device Innovation
bottom line of medical device companies—it’s good for patients as well. Related Reading: New Medical Devices Get To Patients Too Slowly Public R&D Investments and Private-sector Patenting: Evidence from NIH Funding Rules Five... View Details
- 13 May 2014
- Op-Ed
The Alibaba Effect
ago. It has done more for China's small- and medium-sized enterprises than any government policy, ministry, or bank. Alibaba's only limits are those imposed by the speed at which these enterprises continue to grow. Health and welfare... View Details
- May 4, 2023
- Article
Falling Insulin Prices—What Just Happened?
By: Leemore S. Dafny
Recently, more than 100 years after insulin was developed, manufacturers announced price reductions for insulin products. Pressure to reduce prices had long been building, so why would they act now? View Details
Keywords: Price; Health Care and Treatment; Public Opinion; Demand and Consumers; Pharmaceutical Industry
Dafny, Leemore S. "Falling Insulin Prices—What Just Happened?" New England Journal of Medicine 388, no. 18 (May 4, 2023): 1636–1639.
- 29 May 2020
- Op-Ed
How Leaders Are Fighting Food Insecurity on Three Continents
vulnerable families and individuals are suffering from job losses, mental health issues, and food shortages due to significant disruptions in the food system.” SecondBite is a national food relief organization committed to “ending waste,... View Details
- 11 Aug 2014
- HBS Case
The Business of Behavioral Economics
economics and pop culture, particularly since the recent publication of popular books such as Richard Thaler and Cass Sunstein's Nudge, Dan Ariely's Predictably Irrational, and Daniel Kahneman's Thinking, Fast and Slow. Even so,... View Details
- November 2020
- Supplement
Improving Access at VA (Update)
By: Ryan W. Buell
In November 2020, Chief Veterans Experience Officer, Lynda Davis, and Deputy Chief Veterans Experience Officer, Barbara C. Morton reflect on a busy four years leading the Veterans Experience Office at the U.S. Department of Veterans Affairs. The case provides an update... View Details
Keywords: Government; Service Management; Leading Change; Transformation; Service Operations; Management; Health Care and Treatment; Government Administration; Performance Improvement; Public Administration Industry; United States
Buell, Ryan W. "Improving Access at VA (Update)." Harvard Business School Supplement 621-070, November 2020.
- March 2024 (Revised July 2024)
- Case
AMC: The Zero Revenue Case
By: C. Fritz Foley and Donal O'Cofaigh
The onset of the Covid-19 pandemic put theatre company AMC’s already perilous financial situation under even further strain. The company’s high levels of debt resulted in a monthly cash-burn which left it facing an imminent Chapter-11 filing in the absence of... View Details
Keywords: Ethics; Insolvency and Bankruptcy; Public Equity; Stock Shares; Health Pandemics; Entertainment and Recreation Industry
Foley, C. Fritz, and Donal O'Cofaigh. "AMC: The Zero Revenue Case." Harvard Business School Case 224-069, March 2024. (Revised July 2024.)
- 27 Apr 2021
- Research & Ideas
New Research: Surviving Bankruptcy, Useful Economics, and Retirement
use of remote patient monitoring services grows—driven by health care limitations imposed by the COVID-19 pandemic—clinicians, payers, and patients face important questions regarding the volume, value, and appropriate use of this care... View Details
- 16 Oct 2013
- Op-Ed
Response to Readers: Combating Climate Change with Nuclear Power and Fracking
deaths due to severe smog (estimated between 3,000 to more recently 10,000 in London between December 1952 and March 1953) now officially acknowledged and seemingly routine in China today as well as coal burning's lingering cardiovascular and lung disease impacts that... View Details
- 15 Nov 2012
- Research & Ideas
Funding the Design of Livable Cities
urban sustainability initiatives and to create highly efficient and livable spaces. "The challenges of global urban redevelopment are an ideal opportunity for collaboration between the fields of design, finance, public View Details
- 17 Nov 2020
- In Practice
How Retailers Can Thrive in a Shopping Season Like No Other
around promises to be different. Public health measures needed to curb the spread of COVID-19 have pummeled local retailers reliant on foot traffic. Revenues are down across the board. In the face of these... View Details
- 30 Jun 2020
- Book
Capitalism Is More at Risk Than Ever
financial system The state of trade Inequality and populism Migration Environmental degradation Failure of the rule of law The state of public health and general education The rise of state capitalism... View Details
Keywords: by Martha Lagace
- 05 Jan 2016
- Working Paper Summaries
The Integrity of Private Third-party Compliance Monitoring
- 22 Sep 2014
- Op-Ed
Online Banks Fill Funding Needs for Small Business
and electronic payment technology to assess the health of a business. Traditional lenders generally focus on both the small business owners' personal credit history and key metrics about the borrower's business, such as industry-specific... View Details
- 19 Jun 2018
- Research Event
Has Environmental Sustainability Lost its Relevance?
alleged short-term nature of capital markets, and the way the human thought process works. Overcoming roadblocks requires public policies to be much more aligned with creating the right incentives to support long-term commitments and... View Details
- 09 Sep 2008
- First Look
First Look: September 9, 2008
independent social rating agency and avoids selection issues by taking advantage of a natural experiment that arose when the agency expanded the scope of its ratings. We find empirical support for our hypotheses and present implications for managers of rated companies... View Details
Keywords: Sean Silverthorne
- 29 Sep 2015
- First Look
September 29, 2015
myopic sick care focus towards the WHO's true health vision by creating a health system that integrates medical care with public health and... View Details
Keywords: Sean Silverthorne
- January 2006 (Revised May 2007)
- Case
Endo Pharmaceuticals (A): From LBO to...?
By: Richard G. Hamermesh and Brian DeLacey
Endo Pharmaceuticals was formed in 1997 as a leveraged buyout spin-off from DuPont Merck. In 1999, it must decide whether to do an IPO or merge with a smaller company. View Details
Keywords: Private Equity; Initial Public Offering; Leveraged Buyouts; Mergers and Acquisitions; Health Care and Treatment; Pharmaceutical Industry; United States
Hamermesh, Richard G., and Brian DeLacey. "Endo Pharmaceuticals (A): From LBO to...?" Harvard Business School Case 806-064, January 2006. (Revised May 2007.)
- January 2007 (Revised January 2007)
- Background Note
Note on the U.S. Food and Drug Administration
By: Robert F. Higgins, Richard G. Hamermesh and Virginia Fuller
Describes the U.S. FDA with particular emphasis on its role in the development of new drugs, biologic products, and medical devices today. Provides context for the drug approval process by describing the FDA's history and organizational structure. View Details
Keywords: Health; Governance Compliance; Policy; Product Development; Government and Politics; Public Administration Industry; Public Administration Industry; Public Administration Industry; Public Administration Industry; United States
Higgins, Robert F., Richard G. Hamermesh, and Virginia Fuller. "Note on the U.S. Food and Drug Administration." Harvard Business School Background Note 807-050, January 2007. (Revised January 2007.)